314 related articles for article (PubMed ID: 25869896)
1. Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system.
Bottai D; Frigui W; Clark S; Rayner E; Zelmer A; Andreu N; de Jonge MI; Bancroft GJ; Williams A; Brodin P; Brosch R
Vaccine; 2015 May; 33(23):2710-8. PubMed ID: 25869896
[TBL] [Abstract][Full Text] [Related]
2. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
[TBL] [Abstract][Full Text] [Related]
3. ESX-5-targeted export of ESAT-6 in BCG combines enhanced immunogenicity & efficacy against murine tuberculosis with low virulence and reduced persistence.
Heijmenberg I; Husain A; Sathkumara HD; Muruganandah V; Seifert J; Miranda-Hernandez S; Kashyap RS; Field MA; Krishnamoorthy G; Kupz A
Vaccine; 2021 Dec; 39(50):7265-7276. PubMed ID: 34420788
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of protective efficacy conferred by a recombinant Mycobacterium bovis BCG expressing a fusion protein of Ag85A-ESAT-6.
Deng YH; He HY; Zhang BS
J Microbiol Immunol Infect; 2014 Feb; 47(1):48-56. PubMed ID: 23357605
[TBL] [Abstract][Full Text] [Related]
5. Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection.
Gröschel MI; Sayes F; Shin SJ; Frigui W; Pawlik A; Orgeur M; Canetti R; Honoré N; Simeone R; van der Werf TS; Bitter W; Cho SN; Majlessi L; Brosch R
Cell Rep; 2017 Mar; 18(11):2752-2765. PubMed ID: 28297677
[TBL] [Abstract][Full Text] [Related]
6. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
7. Recombinant BCG coexpressing Ag85B, ESAT-6 and mouse-IFN-gamma confers effective protection against Mycobacterium tuberculosis in C57BL/6 mice.
Xu Y; Zhu B; Wang Q; Chen J; Qie Y; Wang J; Wang H; Wang B; Wang H
FEMS Immunol Med Microbiol; 2007 Dec; 51(3):480-7. PubMed ID: 17919299
[TBL] [Abstract][Full Text] [Related]
8. Recombinant BCG coexpressing Ag85B, ESAT-6 and Rv3620c elicits specific Th1 immune responses in C57BL/6 mice.
Yang E; Lu Y; Xu Y; Liang Q; Wang C; Wang H; Shen H
Microb Pathog; 2014; 69-70():53-9. PubMed ID: 24726737
[TBL] [Abstract][Full Text] [Related]
9. Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis.
Pym AS; Brodin P; Majlessi L; Brosch R; Demangel C; Williams A; Griffiths KE; Marchal G; Leclerc C; Cole ST
Nat Med; 2003 May; 9(5):533-9. PubMed ID: 12692540
[TBL] [Abstract][Full Text] [Related]
10. Comparison of BCG prime-DNA booster and rBCG regimens for protection against tuberculosis.
Tan K; Liang J; Teng X; Wang X; Zhang J; Yuan X; Fan X
Hum Vaccin Immunother; 2014; 10(2):391-8. PubMed ID: 24192709
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of immunogenicity and protective efficacy against Mycobacterium tuberculosis infection elicited by recombinant Mycobacterium bovis BCG expressing human Interleukin-12p70 and Early Secretory Antigen Target-6 fusion protein.
Deng Y; Bao L; Yang X
Microbiol Immunol; 2011 Nov; 55(11):798-808. PubMed ID: 21831202
[TBL] [Abstract][Full Text] [Related]
12. Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis.
Sun R; Skeiky YA; Izzo A; Dheenadhayalan V; Imam Z; Penn E; Stagliano K; Haddock S; Mueller S; Fulkerson J; Scanga C; Grover A; Derrick SC; Morris S; Hone DM; Horwitz MA; Kaufmann SH; Sadoff JC
Vaccine; 2009 Jul; 27(33):4412-23. PubMed ID: 19500523
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Genome Region of Difference 4 (RD4) on Mycobacterial Virulence and BCG Efficacy.
Ru H; Liu X; Lin C; Yang J; Chen F; Sun R; Zhang L; Liu J
Front Cell Infect Microbiol; 2017; 7():239. PubMed ID: 28642843
[TBL] [Abstract][Full Text] [Related]
14. Expression and immunogenicity of recombinant Mycobacterium bovis Bacillus Calmette-Guérin strains secreting the antigen ESAT-6 from Mycobacterium tuberculosis in mice.
Wang LM; Shi CH; Fan XL; Xue Y; Bai YL; Xu ZK
Chin Med J (Engl); 2007 Jul; 120(14):1220-5. PubMed ID: 17697571
[TBL] [Abstract][Full Text] [Related]
15. Mucosal delivery of ESX-1-expressing BCG strains provides superior immunity against tuberculosis in murine type 2 diabetes.
Sathkumara HD; Muruganandah V; Cooper MM; Field MA; Alim MA; Brosch R; Ketheesan N; Govan B; Rush CM; Henning L; Kupz A
Proc Natl Acad Sci U S A; 2020 Aug; 117(34):20848-20859. PubMed ID: 32778586
[TBL] [Abstract][Full Text] [Related]
16. Manipulation of BCG vaccine: a double-edged sword.
Singh VK; Srivastava R; Srivastava BS
Eur J Clin Microbiol Infect Dis; 2016 Apr; 35(4):535-43. PubMed ID: 26810060
[TBL] [Abstract][Full Text] [Related]
17. Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis.
Bao L; Chen W; Zhang H; Wang X
Infect Immun; 2003 Apr; 71(4):1656-61. PubMed ID: 12654778
[TBL] [Abstract][Full Text] [Related]
18. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
[TBL] [Abstract][Full Text] [Related]
19. Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein.
Shi C; Chen L; Chen Z; Zhang Y; Zhou Z; Lu J; Fu R; Wang C; Fang Z; Fan X
Vaccine; 2010 Jul; 28(32):5237-44. PubMed ID: 20538090
[TBL] [Abstract][Full Text] [Related]
20. Improved long-term protection against Mycobacterium tuberculosis Beijing/W in mice after intra-dermal inoculation of recombinant BCG expressing latency associated antigens.
Reece ST; Nasser-Eddine A; Dietrich J; Stein M; Zedler U; Schommer-Leitner S; Ottenhoff TH; Andersen P; Kaufmann SH
Vaccine; 2011 Nov; 29(47):8740-4. PubMed ID: 21871515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
